Quest Laboratories Limited (NSE:QUESTLAB)
109.80
-2.20 (-1.96%)
At close: Apr 30, 2025
Quest Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
Revenue | 841.71 | 825.63 | 616.41 | 594.84 | 303.63 | 263.8 |
Revenue Growth (YoY) | - | 33.94% | 3.63% | 95.91% | 15.10% | - |
Cost of Revenue | 504.39 | 523.47 | 419.24 | 446.19 | 245.77 | 220.27 |
Gross Profit | 337.33 | 302.16 | 197.17 | 148.65 | 57.86 | 43.52 |
Selling, General & Admin | 38.25 | 42.84 | 33.59 | 34.77 | 24.1 | 17.44 |
Other Operating Expenses | 123.81 | 103.83 | 83.9 | 48.78 | 18.41 | 15.45 |
Operating Expenses | 167.66 | 152.35 | 122.98 | 88.15 | 46.45 | 36.31 |
Operating Income | 169.67 | 149.81 | 74.19 | 60.5 | 11.41 | 7.21 |
Interest Expense | -9.04 | -7.27 | -5.06 | -2.73 | -2.86 | -3.08 |
Interest & Investment Income | 2.29 | 2.29 | 0.98 | 0.39 | 0.12 | 0.1 |
Other Non Operating Income (Expenses) | 7.38 | -0.37 | -0.32 | -0.23 | -0.21 | -0.05 |
EBT Excluding Unusual Items | 170.3 | 144.46 | 69.78 | 57.93 | 8.46 | 4.19 |
Gain (Loss) on Sale of Assets | - | - | 0.04 | -0.26 | 0.02 | 0.03 |
Pretax Income | 170.3 | 144.46 | 69.82 | 57.67 | 8.48 | 4.22 |
Income Tax Expense | 52.47 | 43.52 | 19.37 | 16.62 | 1.93 | 1.36 |
Net Income | 117.83 | 100.94 | 50.45 | 41.05 | 6.55 | 2.86 |
Net Income to Common | 117.83 | 100.94 | 50.45 | 41.05 | 6.55 | 2.86 |
Net Income Growth | - | 100.08% | 22.90% | 527.01% | 128.74% | - |
Shares Outstanding (Basic) | 15 | 12 | 11 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 15 | 12 | 11 | 11 | 11 | 11 |
Shares Change (YoY) | - | 10.66% | - | - | - | - |
EPS (Basic) | 8.00 | 8.46 | 4.68 | 3.81 | 0.61 | 0.27 |
EPS (Diluted) | 8.00 | 8.46 | 4.68 | 3.81 | 0.61 | 0.27 |
EPS Growth | - | 80.83% | 22.88% | 527.01% | 129.01% | - |
Free Cash Flow | -52.76 | 20.73 | 8.66 | 15.24 | 4.75 | 4.55 |
Free Cash Flow Per Share | -3.58 | 1.74 | 0.80 | 1.41 | 0.44 | 0.42 |
Gross Margin | 40.08% | 36.60% | 31.99% | 24.99% | 19.06% | 16.50% |
Operating Margin | 20.16% | 18.14% | 12.04% | 10.17% | 3.76% | 2.73% |
Profit Margin | 14.00% | 12.23% | 8.18% | 6.90% | 2.16% | 1.08% |
Free Cash Flow Margin | -6.27% | 2.51% | 1.41% | 2.56% | 1.56% | 1.72% |
EBITDA | 175.27 | 155.49 | 79.68 | 65.1 | 15.35 | 10.63 |
EBITDA Margin | 20.82% | 18.83% | 12.93% | 10.95% | 5.05% | 4.03% |
D&A For EBITDA | 5.6 | 5.68 | 5.5 | 4.6 | 3.94 | 3.42 |
EBIT | 169.67 | 149.81 | 74.19 | 60.5 | 11.41 | 7.21 |
EBIT Margin | 20.16% | 18.14% | 12.04% | 10.17% | 3.76% | 2.73% |
Effective Tax Rate | 30.81% | 30.13% | 27.74% | 28.82% | 22.79% | 32.19% |
Revenue as Reported | 851.76 | 827.92 | 618.66 | 595.42 | 304.13 | 264.39 |
Advertising Expenses | - | 0.08 | 0.04 | 0.01 | 0.01 | - |
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.